Table 7 Pattern of post-COVID-19 infection based on types of vaccine (N = 70)

Vaccination

Partial

5 (16.1%)

3 (18.8%)

6 (42.9%)

0

2 (40%)

1 (33.3%)

Fully

26 (83.9%)

13 (81.3%)

8 (57.1%)

1 (100%)

3 (60%)

2 (66.7%)

0.39

Incidence

  > 14 days of 1st dose

4 (12.9%)

4 (25%)

9 (64.3%)

0

1 (20%)

1 (33.3%)

  > 28 days of 1st dose

5 (16.1%)

1 (6.3%)

0

0

2 (40%)

0

0.09

  > 14 days of 2nd dose

5 (16.1%)

1 (6.3%)

0

0

0

0

  > 28 days of 2nd dose

17 (54.8%)

10 (62.5%)

5 (62.5%)

1 (100%)

2 (40%)

2 (66.7%)

Duration from vaccine

56 (14–303)

50 (13–183)

22 (15–195)

85

31 (14–88)

60 (17–126)

 < 0.001

Diagnostic CT^a

5 (16.1%)

7 (43.8%)

6 (42.9%)

1 (100%)

1 (20%)

1 (33.3%)

0.15

Diagnostic swab

12 (38.7%)

4 (25%)

4 (28.6%)

0

2 (40%)

0

0.68

Diagnostic symptoms^b

31 (100%)

16 (100%)

13 (92.9%)

1 (100%)

5 (100%)

3 (100%)

0.54

Fever

28 (90.3%)

16 (100%)

11 (78.6%)

1 (100%)

4 (80%)

3 (100%)

0.43

Headache

24 (77.4%)

13 (81.3%)

10 (71.4%)

1 (100%)

3 (60%)

2 (66.7%)

0.90

Myalgia

26 (83.9%)

16 (100%)

10 (71.4%)

1 (100%)

3 (60%)

3 (100%)

0.17

Ageusia

9 (29%)

5 (31.3%)

2 (14.3%)

0

2 (40%)

0

0.65

Anosmia

10 (32.3%)

4 (25%)

4 (28.6%)

0

2 (40%)

0

0.81

Cough

23 (74.2%)

13 (81.3%)

10 (71.4%)

0

4 (80%)

2 (66.7%)

0.61

Diarrhea

1 (3.2%)

3 (18.8%)

0

0

2 (40%)

1 (33.3%)

0.04

Rhinorrhea

9 (29%)

5 (31.3%)

4 (28.6%)

0

2 (40%)

1 (33.3%)

0.98

Sore throat

11 (35.5%)

7 (43.8%)

5 (35.7%)

1 (100%)

2 (40%)

2 (66.7%)

0.72

Dyspnea

11 (35.5%)

11 (68.8%)

8 (57.1%)

1 (100%)

1 (20%)

0

0.06

Care site treatment

 Home isolation

26 (83.9%)

9 (56.3%)

10 (71.4%)

0

3 (60%)

2 (66.7%)

 Oxygen therapy

0

1 (6.3%)

0

0

0

0

0.54

 Hospital admission

2 (6.5%)

4 (25%)

3 (21.4%)

1 (100%)

1 (20%)

1 (33.3%)

 ICU admission

3 (9.7%)

2 (12.5%)

1 (7.1%)

0

1 (20%)

0